Clinic
Nor-Lea Hospital District
Nor-Lea Hospital District was paid $6.83M by Medicaid between Jan 2018 and Dec 2024, across 51 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
33Billing provider infoNOR-LEA HOSPITAL DISTRICT
HOBBS, NM 88240
HOBBS, NM 88240
33aNPI1992171433assigned 08/19/2015
33bProvider typeRural Health Clinic/Center
28Total paid$6.83M
24GClaims124,778
24DCodes billed51
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in New Mexico
Rank by total paid#3 of 11
Median peer was paid$2.62M
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,317 | $748K | |
| 2019 | 17,107 | $846K | |
| 2020 | 13,775 | $619K | |
| 2021 | 14,465 | $727K | |
| 2022 | 15,549 | $856K | |
| 2023 | 23,298 | $1.57M | |
| 2024incomplete | 23,267 | $1.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 33,379 | 30,517 | $2.75M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 36,003 | 31,737 | $2.69M |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.9% | 11,669 | 11,164 | $195K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 8,307 | 6,029 | $172K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 1,564 | 1,537 | $126K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.7% | 1,513 | 1,509 | $115K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.4% | 1,457 | 1,244 | $94K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 1,184 | 1,162 | $93K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.3% | 1,325 | 1,321 | $90K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 1,303 | 1,276 | $89K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,034 | 3,716 | $54K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 462 | 461 | $43K |
39 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 349 | $33K |
| 87254 | <1% | 3,061 | $32K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,721 | $30K |
| 87430 | <1% | 3,073 | $28K | |
| 90461 | <1% | 1,513 | $25K | |
| 81002 | <1% | 1,994 | $22K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,311 | $22K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 130 | $15K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 382 | $14K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,555 | $12K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 118 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 567 | $10K |
| 81003 | <1% | 1,283 | $10K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 784 | $9K |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 206 | $9K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 131 | $7K |
| 81025 | <1% | 405 | $7K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 457 | $6K |
| 85018 | <1% | 229 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,035 | $2K |
| 99385 | <1% | 12 | $2K | |
| 99381 | <1% | 25 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 268 | $2K |
| 87807 | <1% | 90 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 24 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 88 | $929.84 |
| 82962 | <1% | 74 | $373.92 | |
| 99173 | <1% | 91 | $226.75 | |
| 90715 | <1% | 13 | $192.81 | |
| 96127 | <1% | 38 | $160.17 | |
| 90658 | <1% | 75 | $128.37 | |
| 90670 | <1% | 225 | $96.29 | |
| 94664 | <1% | 12 | $83.62 | |
| 99406 | <1% | 29 | $33.10 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 30 | $29.24 |
| 90633 | <1% | 25 | $0.03 | |
| 90648 | <1% | 73 | $0.01 | |
| 90651 | 0% | 12 | $0.00 | |
| 90756 | 0% | 70 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHAW, DAVID (CEO/ADMINISTRATOR)
Parent organizationNOR-LEA HOSPITAL DISTRICT
| Provider | Location | Paid |
|---|---|---|
| Nor-Lea Hospital District | Lovington, NM | $53.24M |
| Nor-Lea Hospital District | Lovington, NM | $18.25M |
| Nor-Lea Hospital District | Hobbs, NM | $2.02M |
| Nor-Lea Hospital District | Tatum, NM | $254K |
| Nor-Lea Hospital District | Lovington, NM | $251K |
| Nor-Lea Hospital District | Lovington, NM | $98K |
| Nor-Lea Hospital District | Hobbs, NM | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.